End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
787,000 KRW | +0.77% | +1.55% | +3.55% |
May. 06 | Samsung Group Firms Set to Invest in US-based Latus Bio | MT |
Apr. 25 | Samsung Bioepis Granted Approval to Market Autoimmune Treatment in Europe | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.55% | 40.9B | |
-2.61% | 89.08B | |
-14.40% | 32.25B | |
+55.89% | 25.14B | |
-15.96% | 15.39B | |
-15.50% | 11.91B | |
-41.29% | 11.89B | |
-11.75% | 11.64B | |
+7.87% | 9.03B | |
-3.16% | 8.62B |
- Stock Market
- Equities
- A207940 Stock
- News Samsung Biologics Co.,Ltd.
- Samsung Biologics Co.,Ltd. Announces Sales Results for the Year 2020